Clinical Trial Update: Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC [Phase 3]

View source ↗

Summary

A Phase III trial evaluating RRM1 and ERCC1 directed customized chemotherapy for non-small cell lung cancer has completed and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RRM1 & ERCC1 directed customized chemotherapy

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-03-26